Form 4: Metsera Inc. Executive Chairman Clive Meanwell Granted Stock Options
SEC Form 4 Filing
Clive Meanwell, Executive Chairman of Metsera, Inc., reports the acquisition of stock options.
Summary
- Clive Meanwell, the Executive Chairman of Metsera, Inc., filed a Form 4 with the SEC.
- The filing reports the grant of stock options to Meanwell on May 20, 2025.
- The options grant Meanwell the right to buy 32,250 shares of Metsera's common stock at an exercise price of $29.25 per share.
- The options vest in 12 substantially equal monthly installments, becoming fully vested on the first anniversary of the grant date, contingent upon continued service.
- Meanwell also provided a Power of Attorney, effective October 29, 2024, designating Christopher Whitten, Bernard Christopher J. Visioli, and Matthew Lang as attorneys-in-fact for Section 16 filings.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The grant of stock options is a standard practice and generally viewed favorably as it aligns management's interests with shareholders. There are no indications of negative news or concerns.
Positives
- The grant of stock options aligns the Executive Chairman's interests with those of the shareholders.
- The vesting schedule incentivizes continued service and commitment to the company.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the options.
Industry Context
Stock option grants are a common practice to incentivize and retain key executives in publicly traded companies, aligning their interests with shareholder value.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in the pharmaceutical and biotechnology industries, similar to companies like Amgen, Gilead Sciences, and Regeneron.
- The vesting schedule of 12 months is a typical vesting period for executive stock options.
Stakeholder Impact
- Shareholders may view the option grant positively as it incentivizes the Executive Chairman.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 2024-10-29 | Date of Power of Attorney execution. |
| 2025-05-20 | Date of stock option grant. |
| 2025-05-22 | Date of Form 4 filing. |
| 2035-05-19 | Expiration date of the stock options. |
Keywords
Form 4, Stock Options, Metsera, Clive Meanwell, Executive Chairman, Beneficial Ownership, SEC Filing, Power of Attorney
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.